Biorce researches and develops biotechnological solutions for sustainable agriculture and health through microbial innovation.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Biorce's AI operating system for clinical trials cuts protocol creation from 18 months to 10 minutes with 95% accuracy, reducing pharma R&D costs by 50-70%. The company achieved ~$10M ARR in 9 months with 250K-10M+ EUR annual contracts, 70% on 3-year terms, and turned down a ~$2B acquisition offer to pursue infrastructure play.